MB
MPM BioImpact LLC cut its DBVT stake below 5%
MPM BioImpact LLC reported owning 4.8% of DBV Technologies S.A. (DBVT) (15,223,295 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G